Abstract

Aortic stenosis (AS) is the most commonly encountered valvular disease in developed countries. Once symptomatic, this disease carries a dismal prognosis. Patients unfit for surgical valve replacement may require transcatheter aortic valve implantations (TAVI). We present a complication of this novel approach where a prosthetic valve is delivered through the femoral artery by means of a Retroflex delivery system developed by Edwards Lifesciences.

Highlights

  • An 81-year-old woman was admitted to hospital for symptomatic aortic stenosis (AS) in July 2010, with a history of moderate AS, mild-moderate aortic regurgitation, moderate mitral regurgitation, paroxysmal atrial fibrillation and pacemaker implantation for a 2:1 atrioventricular heart block

  • It was felt that a transcatheter valve would be a safer option, and she underwent the transcatheter aortic valve implantation (TAVI) procedure in April 2011

  • Pericardial tamponade has been documented with the CoreValve to occur between 0 and 7%, and is usually due to guidewire or manoeuvring thrusts to bring the prosthesis into the left ventricle that can potentially cause peforations.[3]

Read more

Summary

Ventricular perforation as a complication of percutaneous valve replacement

Cornelis de Jager, BSc College of Medicine, University of Saskatchewan, Saskatoon, Canada. It was felt that a transcatheter valve would be a safer option, and she underwent the transcatheter aortic valve implantation (TAVI) procedure in April 2011. She received an aortic 23 mm Edward Sapien XT (9300 TFX) prosthesis in what was described as a successful procedure at the time. The patient developed bilateral pleural effusions over the interval, thought to be related to congestive heart failure (Fig. 3). After treatment with diuretics and thoracocentesis, the patient was discharged, only to be re-admitted a week later for worsening bilateral pleural effusions. At the 2-month follow-up, the patient was still being treated in hospital for pleural effusions by means of diuretics, thoracocentesis and supportive treatment

Findings
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.